Search for drugs:
Typing the drug name to query
CROFELEMER
DIR Classification
Classification:Ambiguous
Severity Score:1.0
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- CLINICAL PHARMACOLOGY
- Pharmacodynamics
- Cardiac Electrophysiology
- At a dose 10 times the maximum recommended dose, crofelemer does not prolong the QTc interval to any clinically relevant extent.
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
0
38381587
Odds Ratio = N/A
Drug Property Information
ATC Code(s):
- A07XA06 - crofelemer
- A07XA0 -
- A07XA - Other antidiarrheals
- A07X - OTHER ANTIDIARRHEALS
- A07 - "ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE "
- A - ALIMENTARY TRACT AND METABOLISM
Active Ingredient:CROFELEMER
Active Ingredient UNII:PY79D6C8RX
Drugbank ID:DB04941
PubChem Compound:N/ADIR Classification
CTD ID:C080461
CAS Number:148465-45-6
Dosage Form(s):tablet, coated
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure: 
SMILE Code:
Reference
N/A
Disclaimer:
The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
Any mention of commercial products is for clarification and not intended as endorsement.